MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells

被引:51
作者
Gotanda, Keisuke [1 ]
Hirota, Takeshi [1 ]
Matsumoto, Nozomi [1 ]
Ieiri, Ichiro [1 ]
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Higashi Ku, Fukuoka 8128582, Japan
来源
BMC CANCER | 2013年 / 13卷
关键词
MicroRNAs; miR-433; Thymidylate synthase; Fluorouracil; COLORECTAL-CANCER PATIENTS; MESSENGER-RNA; DIHYDROPYRIMIDINE DEHYDROGENASE; GASTRIC-CARCINOMA; DOSE ADJUSTMENT; GENE; RESISTANCE; POLYMORPHISM; CHEMOTHERAPY; 5-FU;
D O I
10.1186/1471-2407-13-369
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Thymidylate synthase (TYMS) is an important folate-dependent enzyme in DNA synthesis and an important target for cancer chemotherapy. High TYMS expression levels in tumors are generally associated with resistance to 5-fluorouracil (5-FU). The cause of the variability in TYMS expression is still not fully understood, however, only a small proportion of the TYMS expression can be explained by TYMS genetic polymorphisms. The purpose of this study is to identify novel microRNAs (miRNAs) which regulate the expression of TYMS and to determine whether miRNAs binding to the 3'-untranslated region (UTR) of TYMS mRNA affect the proliferation of HeLa cells treated with 5-FU. Methods: An in silico search was performed to find potential binding sites of miRNAs in TYMS mRNA. The efficacy of predicted miRNAs at the 3'-UTR of TYMS mRNA was evaluated using a dual-luciferase reporter assay. TYMS mRNA and protein expression in HeLa cells was quantified with real-time RT-PCR and Western blotting, respectively. The effects of miR-433 on cell proliferative activity were determined by WST-8 assay. Results: The overexpression of miR-433 was associated with significantly decreased reporter activity in the plasmid containing the 3'-UTR of TYMS mRNA (P < 0.01). The levels of TYMS mRNA and protein in HeLa cells were significantly decreased by the overexpression of miR-433 (P < 0.05). Furthermore, miR-433 increased inhibition of cell proliferation in HeLa cells treated with 5-FU at over 2.0 mu M. Conclusion: The results indicate that miR-433 post-transcriptionally regulates the expression of TYMS mRNA and protein, and increases sensitivity to 5-FU in HeLa cells. This is the first report showing that a miRNA regulating TYMS expression has a significant impact on sensitivity to 5-FU treatment.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer
    Nita, ME
    Tominaga, O
    Tsuruo, T
    Muto, T
    HEPATO-GASTROENTEROLOGY, 1998, 45 (24) : 2117 - 2122
  • [12] Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity
    M-C Etienne
    K Ilc
    J-L Formento
    P Laurent-Puig
    P Formento
    S Cheradame
    J-L Fischel
    G Milano
    British Journal of Cancer, 2004, 90 : 526 - 534
  • [13] Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells
    Saga, Y
    Suzuki, M
    Mizukami, H
    Kohno, T
    Takei, Y
    Fukushima, M
    Ozawa, K
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) : 324 - 326
  • [14] High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro
    Habara, K
    Ajiki, T
    Kamigaki, T
    Nakamura, T
    Kuroda, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (10): : 1127 - 1132
  • [15] The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells
    Oguri, T
    Achiwa, H
    Bessho, Y
    Muramatsu, H
    Maeda, H
    Niimi, T
    Sato, S
    Ueda, R
    LUNG CANCER, 2005, 49 (03) : 345 - 351
  • [16] The First Case of Severe Takotsubo Cardiomyopathy Associated with 5-Fluorouracil in a Patient with Abnormalities of Both Dihydropyrimidine Dehydrogenase (DPYD) and Thymidylate Synthase (TYMS) Genes
    Saif, Muhammad W.
    Smith, Melissa
    Maloney, Antonio
    CUREUS, 2016, 8 (09):
  • [17] Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil
    Showalter, Shayna L.
    Showalter, Timothy N.
    Witkiewicz, Agnes
    Havens, Robert
    Kennedy, Eugene P.
    Hucl, Tomas
    Kern, Scott E.
    Yeo, Charles J.
    Brody, Jonathan R.
    CANCER BIOLOGY & THERAPY, 2008, 7 (07) : 986 - 994
  • [18] Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients
    Abdallah, Emne Ali
    Fanelli, Marcello Ferretti
    Cavicchioli Buim, Marcilei Eliza
    Machado Netto, Marcelo Calil
    Gasparini Junior, Jose Luiz
    Souza e Silva, Virgilio
    Abbade Dettino, Aldo Lourenco
    Mingues, Natalia Breve
    Romero, Juliana Valim
    Mendonca Ocea, Luciana Menezes
    Malagoli Rocha, Bruna Maria
    Alves, Vanessa Silva
    Araujo, Daniel Vilarim
    Domingos Chinen, Ludmilla Thome
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (06) : 1397 - 1405
  • [19] Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
    Nakamura, Ayako
    Nakajima, Go
    Okuyama, Ryuji
    Kuramochi, Hidekazu
    Kondoh, Yurin
    Kanemura, Toshinori
    Takechi, Teiji
    Yamamoto, Masakazu
    Hayashi, Kazuhiko
    GASTRIC CANCER, 2014, 17 (01) : 188 - 195
  • [20] Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells
    Nabeya, Yoshihiro
    Suzuki, Takao
    Furuya, Aki
    Koide, Naoki
    Ohkoshi, Motohiro
    Takiguchi, Masaki
    Ochiai, Takenori
    Matsubara, Hisahiro
    Hiwasa, Takaki
    CANCER SCIENCE, 2011, 102 (08) : 1509 - 1515